¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ ½ÉÆ÷Áö¾ö : 2019-06-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ ½ÉÆ÷Áö¾ö : 2019-06-22
±³À°ÀÏÀÚ : 2019-06-22
±³À°Àå¼Ò : ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101, 102È£  
±³À°ÁÖÁ¦ : 2019³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ 
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ±Ù¿¬±¸È¸  
´ã´çÀÚ : Çѹμö
¿¬¶ôó : 031-981-2764  
À̸ÞÀÏ : daonics@naver.com      
±³À°Á¾·ù : ¸¶ÃëÅëÁõÀÇÇаú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : °­¿øµµ
±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í µî·Ïºñ ±¸ºÐ »çÀüµî·Ï ÇöÀåµî·Ï ¿¬È¸ºñ Á¤È¸¿ø(Àü¹®ÀÇ) ¹«·áµî·Ï ¹«·áµî·Ï 50,000¿ø ºñȸ¿ø(Àü¹®ÀÇ) 30,000¿ø 40,000¿ø ¾øÀ½ ½ÅÀÔȸ¿ø(Àü¹®ÀÇ) ¾øÀ½ ¾øÀ½ 50,000¿ø Àü°øÀÇ ¹× ±âŸÀÇ·áÁø 20,000¿ø 30,000¿ø ¾øÀ½      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 09:00~09:25 Clinical applications of neuromuscular monitoring  ¼­Á¤È­(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 09:25~09:50 Current evidence-based recommendations for monitoring and reversal  ±èÁø¼±(°­¸ª¾Æ»êº´¿ø) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 09:50~10:15 Malignant hyperthermia and muscle-related disorder  ±è±Ô³²(ÇѾçÀÇ´ë) 
Åä·Ð 06-22  10:15~10:35 Q & A  () 
È޽Ġ06-22  10:35~10:50 Break  () 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 10:50~11:15 Clinical applications of neuromuscular monitoring  ¾çÈ«¼®(´ëÀü ¼±º´¿ø) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 11:15~11:40 Current evidence-based recommendations for monitoring and reversal  ÀÌ¿øÁø(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 11:45~12:05 Malignant hyperthermia and muscle-related disorder  ÃÖÀç¹®(¿ï»êÀÇ´ë) 
Åä·Ð 06-22  12:05~12:25 Q & A  () 
½Ä»ç 06-22  12:30~13:30 Lunch  () 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 13:30~13:55 Recent literature review; sugammadex: what do we know and what do we still need to know?  Á¤±âÅÂ(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 13:55~14:20 Statistical/methodology: randomization  ÀÎÁØ¿ë(µ¿±¹ÀÇ´ë) 
Åä·Ð 06-22  14:20~14:35 Q & A  () 
È޽Ġ06-22  14:35~14:50 Break  () 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 14:50~15:10 Retrospective analysis of 30-day unplanned readmission after major abdominal surgery with reversal by sugammadex or neostigmine  ¿ÀŹ±Ô(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 15:10~15:30 Effects of magnesium chloride on rocuronium-induced neuromuscular blockade and sugammadex reversal in an isolated rat phrenic nerve-hemidiaphragm preparation  ¼ºÅÂÀ±(°Ç¾çÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 15:30~15:50 Comparison of rocuronium-induced neuromuscular blockade in second trimester pregnant women and non-pregnant women  ÀüÀÎÁ¤(ÇѸ²ÀÇ´ë) 
Åä·Ð 06-22  15:50~16:10 Q & A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ ½ÉÆ÷Áö¾ö : 2019-06-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2019³â Á¦1Â÷ ´ëÇÑÁßȯÀÚÀÇÇÐȸ ´ëÀüÃæûÁöȸ ¿¬¼ö±³À° : 2019-06-22
´ÙÀ½±Û 2019 °¡Ãµ´ë ±æº´¿ø-ÀÎõÁ¤Çü¿Ü°úÀÇ»çȸ ¿¬¼ö °­Á : 2019-06-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 75 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 41 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 55 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 45 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 46 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 22 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 48 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 35 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 29 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷